South Korean Brand Mons to Introduce New Bubblemon 2ml Model with RELX Symbol

Market by 2FIRSTS.ai

Apr.11.2024

Mons to launch new e-cigarette "Bubblemon 2ml" with aqua and pink mon flavors; improved user experience and competitive pricing.

According to a report by South Korean media outlet BusinessKorea on April 11, the e-cigarette brand Mons recently announced that they will be launching a new e-cigarette model called "Bubblemon 2ml.

Co-branded product | Image source: 2FIRSTS

According to reports, the new product will come in two different scents, "aqua" and "pink mon", with an e-liquid capacity of 2 milliliters and a nicotine content of 0.98%. The e-cigarette measures 11.3cm x 1.0cm x 2.1cm and weighs 29 grams, and it is powered by a 3.7V/500mAh battery.

This product uses naturally extracted nicotine from tobacco and a sensor, allowing for immediate use without the need for lighting.

A company spokesperson stated that the new e-cigarette model focuses on enhancing consumer experience and offers better value for money compared to the previous 1.2ml products. It is reported that the product will be available for purchase at GS25 stores starting on the 15th.

It is worth mentioning that in addition to the iconic Mons logo, the design of this product also includes the "RELX" symbol at the bottom. This symbol was not present in Mons' previous releases of Bubble Pop, BILLOW BLACK, and BILLOW WHITE.

RELX and Bubblemon recently launched a disposable e-cigarette in the UK market.

References:

[1] 몬스, ‘버블몬 2ml' 신제품 2종 출시

Also Read:

[1] China Boton Announces Sale of Subsidiary Mons

#Asia #Disposable e-cigarettes #Products #South Korea #RELX Technology

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Australian Border Force Blocks Massive Vape Shipment Following China Intelligence

Australia has seized more than 600,000 illicit vapes in two months, following coordinated intelligence with overseas partners. The Australian Border Force (ABF) warns that illegal vaping products now form a multibillion-dollar black market dominated by organised crime syndicates.

Nov.21 by 2FIRSTS.ai

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

Leaked EU Paper Suggests COP11 Push to Ban Nicotine Pouches and Flavoured Nicotine Products

According to media reports, a leaked European Commission document indicates the EU plans to push for its strictest regulatory framework on nicotine and tobacco products at COP11 in Switzerland this November, including measures such as a full ban on nicotine pouches and flavoured products.

Oct.10 by 2FIRSTS.ai

Smoore: Profit Growth Gradually Improving, Fourth Quarter Shows Promise — A 2Firsts Reader Submission

Smoore released its financial results for the third quarter of 2025.A reader submitted to 2Firsts, noting that Smoore’s declining profit margin was mainly due to the substantial upfront investment in its new heated tobacco products, the relatively low margins of vaping devices, and price reductions resulting from product iterations in the European atomization market.as product structure adjustments near completion, the company’s profit growth is expected to further rebound in the fourth quart.